Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H14N4O2 |
InChIKeyDFURSNCTQGJRRX-JYRVWZFOSA-N |
CAS Registry946843-63-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 Jul 2007 |